BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 11, 2026
Home
»
Newsletters
» BioWorld
BioWorld
Sep. 27, 2004
View Archived Issues
Money Raised Year To Date
Read More
Stock Winners and Losers For The Week
Read More
Biotech Mergers And Acquisitions: May 27 - Sept. 22, 2004#
Read More
Tarceva Ushering OSI Toward Critical Juncture' In Evolution
Tarceva, the eye-opening cancer drug with a new drug application pending, typically is regarded as another feather in the cap of Genentech Inc., whose headgear already is festooned with plumage.
Read More
BioWorld Stock Report For Public Biotechnology Companies
Read More
